Hong Kong Stock Movement | Haixi New Drug (02637.HK) rose more than 5% intraday; HX9428 will enter the optimal window period for BD negotiation cooperation to accelerate global Phase 3 development.
Zhito Finance APP has learned that Haixi New Drug (02637.HK) rose more than 5% during intraday trading. As of press time, it was up 4.29%, at HK$160.5, with a turnover of HK$10.7353 million.
Latest
